Type something to search the website
Key publication
941
Therapeutic Areas
Methods & challenges

Key publication

Pharmacokinetics, safety, tolerability and fluorescence imaging of nizaracianine triflutate administered in three divided doses to healthy volunteers

Key publication

Pharmacokinetics and pharmacodynamics of intravenous and oral (S)-ketamine: Investigating metabolite contribution to subjective effects

Key publication

Lack of improvement after short-term topical antistaphylococcal endolysin SA.100 therapy in patients with mild-to-moderate atopic dermatitis: Results from a randomized, vehicle-controlled trial

Key publication

Effects of Selective Sphingosine-1-Phosphate Receptor 1 Agonist, TRV045, on Evoked Pain Tests: An Exploratory, Four-Way Cross-Over Study in Healthy Volunteers

Key publication

Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants

Key publication

Sustained pharmacodynamic effects of S-ketamine on cortical excitability and resting-state brain activity: A randomized, placebo-controlled trial

Key publication

Motivations and experiences in controlled human infection trials vs. phase I clinical trials: a survey study

Key publication

First-in-human (phase I) trial of SOL-116, a humanised IgG4 monoclonal antibody targeting bile salt-stimulated lipase, in healthy participants and rheumatoid arthritis patients

Key publication

Refining the regulatory and ethics context of controlled human infection models - a stakeholder meeting report

22 June 2026

Biologicals : journal of the International Association of Biological Standardization

Read Publication